Position in BCRX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$257,040
-$372,366 QoQ
Shares Held
27,000
-38.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $41,885,898 across 15 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
237,003 | $17,031,034 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
470,178 | $15,929,630 | |
| 3 | LQDA |
Liquidia Corp
|
60,962 | $4,860,500 | |
| 4 | ALKS |
Alkermes plc.
|
22,074 | $1,156,677 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,857 | $481,518 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
12,421 | $430,636 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
86,475 | $426,321 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
761 | $412,330 |
All Filings in BCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $257,040 | 27,000 | Shares | Defined | 2026-05-08 | |
| 2021-09-30 | $629,406 | 43,800 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $803,148 | 50,800 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $364,086 | 35,800 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $266,710 | 35,800 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||